Patents by Inventor Sam L. Teichman

Sam L. Teichman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING DISEASES
    Publication number: 20240082343
    Abstract: Methods of treating acromegaly in a subject are described herein. Exemplary methods include orally administering to the subject at least once daily at least one dosage form comprising octreotide, wherein the octreotide in each dosage form is 20 mg, and wherein the administering occurs at least 1 hour before a meal or at least 2 hours after a meal.
    Type: Application
    Filed: November 20, 2023
    Publication date: March 14, 2024
    Inventors: Roni MAMLUK, Sam L. TEICHMAN
  • PRODRUG OF A PHENOLIC TRPV1 AGONIST FOR THE TREATMENT OF PAIN
    Publication number: 20240058316
    Abstract: Described herein is a prodrug of a transient receptor potential vanilloid 1 receptor (TRPV1) agonist for the treatment of pain.
    Type: Application
    Filed: December 13, 2021
    Publication date: February 22, 2024
    Inventors: Sam L. TEICHMAN, Susan KRAMER, John F. DONOVAN
  • ORAL OCTREOTIDE THERAPY IN COMBINATION WITH DIGOXIN OR LISINOPRIL
    Publication number: 20240050533
    Abstract: This invention relates to methods of co-administering oral octreotide and digoxin or lisinopril to a subject in need thereof.
    Type: Application
    Filed: June 15, 2023
    Publication date: February 15, 2024
    Inventors: Sam L. TEICHMAN, Asi HAVIV, Jennings Ray DAWKINS, Ruth Engle STEVENS
  • ORAL OCTREOTIDE THERAPY IN COMBINATION WITH DIGOXIN OR LISINOPRIL
    Publication number: 20220202911
    Abstract: This invention relates to methods of co-administering oral octreotide and digoxin or lisinopril to a subject in need thereof.
    Type: Application
    Filed: December 28, 2020
    Publication date: June 30, 2022
    Inventors: Sam L. Teichman, Asi Haviv, Jennings Ray Dawkins, Ruth Engle Stevens
  • Method of treating diseases
    Patent number: 11338011
    Abstract: Methods of treating acromegaly in a subject are described herein. Exemplary methods include orally administering to the subject at least once daily at least one dosage form comprising octreotide, wherein the octreotide in each dosage form is 20 mg, and wherein the administering occurs at least 1 hour before a meal or at least 2 hours after a meal.
    Type: Grant
    Filed: November 10, 2020
    Date of Patent: May 24, 2022
    Assignee: Amryt Endo, Inc.
    Inventors: Roni Mamluk, Sam L. Teichman
  • Method of treating diseases
    Patent number: 11052126
    Abstract: Methods of treating acromegaly in a subject are described herein. Exemplary methods include orally administering to the subject at least once daily at least one dosage form comprising octreotide, wherein the octreotide in each dosage form is 20 mg, and wherein the administering occurs at least 1 hour before a meal or at least 2 hours after a meal.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: July 6, 2021
    Assignee: Chiasma, Inc.
    Inventors: Roni Mamluk, Sam L. Teichman
  • METHOD OF TREATING DISEASES
    Publication number: 20210052691
    Abstract: Methods of treating acromegaly in a subject are described herein. Exemplary methods include orally administering to the subject at least once daily at least one dosage form comprising octreotide, wherein the octreotide in each dosage form is 20 mg, and wherein the administering occurs at least 1 hour before a meal or at least 2 hours after a meal.
    Type: Application
    Filed: November 10, 2020
    Publication date: February 25, 2021
    Inventors: Roni Mamluk, Sam L. Teichman
  • METHOD OF TREATING DISEASES
    Publication number: 20200390847
    Abstract: Methods of treating acromegaly in a subject are described herein. Exemplary methods include orally administering to the subject at least once daily at least one dosage form comprising octreotide, wherein the octreotide in each dosage form is 20 mg, and wherein the administering occurs at least 1 hour before a meal or at least 2 hours after a meal.
    Type: Application
    Filed: May 22, 2020
    Publication date: December 17, 2020
    Inventors: Roni Mamluk, Sam L. Teichman
  • Method of treating diseases
    Patent number: 10695397
    Abstract: Methods of treating acromegaly in a subject are described herein. Exemplary methods include orally administering to the subject at least once daily at least one dosage form comprising octreotide, wherein the octreotide in each dosage form is 20 mg, and wherein the administering occurs at least 1 hour before a meal or at least 2 hours after a meal.
    Type: Grant
    Filed: December 27, 2018
    Date of Patent: June 30, 2020
    Assignee: Chiasma, Inc.
    Inventors: Roni Mamluk, Sam L. Teichman
  • METHOD OF TREATING DISEASES
    Publication number: 20190298792
    Abstract: Methods of treating acromegaly in a subject are described herein. Exemplary methods include orally administering to the subject at least once daily at least one dosage form comprising octreotide, wherein the octreotide in each dosage form is 20 mg, and wherein the administering occurs at least 1 hour before a meal or at least 2 hours after a meal.
    Type: Application
    Filed: December 27, 2018
    Publication date: October 3, 2019
    Inventors: Roni Mamluk, Sam L. Teichman
  • Method of treating diseases
    Patent number: 10238709
    Abstract: Methods of treating acromegaly in a subject are described herein. Exemplary methods include orally administering to the subject at least once daily at least one dosage form comprising octreotide, wherein the octreotide in each dosage form is 20 mg, and wherein the administering occurs at least 1 hour before a meal or at least 2 hours after a meal.
    Type: Grant
    Filed: February 3, 2016
    Date of Patent: March 26, 2019
    Assignee: Chiasma, Inc.
    Inventors: Roni Mamluk, Sam L. Teichman
  • Method of treating dyspnea associated with acute heart failure
    Publication number: 20170151311
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Application
    Filed: January 23, 2017
    Publication date: June 1, 2017
    Inventors: Elaine Unemori, Sam L Teichman, Gad Cotter, Dennis Stewart, Martha Jo Whitehouse
  • Method of lowering mortality
    Patent number: 9579363
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: February 28, 2017
    Assignee: Corthera Inc.
    Inventors: Elaine Unemori, Sam L Teichman, Gad Cotter, Dennis Stewart, Martha Jo Whitehouse
  • Method of lowering mortality
    Patent number: 9205132
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: December 8, 2015
    Assignee: CORTHERA, INC.
    Inventors: Elaine Unemori, Sam L. Teichman, Gad Cotter, Dennis Stewart, Martha Jo Whitehouse
  • Method of treating dyspnea associated with acute heart failure
    Publication number: 20150320834
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Application
    Filed: May 28, 2015
    Publication date: November 12, 2015
    Inventors: Elaine Unemori, Sam L. Teichman, Gad Cotter, Dennis Stewart, Martha Jo Whitehouse
  • METHOD OF TREATING DYSPNEA ASSOCIATED WITH ACUTE HEART FAILURE
    Publication number: 20130210730
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Application
    Filed: March 5, 2013
    Publication date: August 15, 2013
    Applicant: NOVARTIS AG
    Inventors: Elaine Unemori, Sam L. Teichman, Gad Cotter, Dennis Stewart, Martha Jo Whitehouse
  • Method of treating dyspnea associated with acute heart failure by administering H2 relaxin
    Patent number: 8415301
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Grant
    Filed: May 15, 2009
    Date of Patent: April 9, 2013
    Assignee: Corthera, Inc.
    Inventors: Elaine Unemori, Sam L Teichman, Gad Cotter, Dennis R Stewart, Martha J Whitehouse
  • Method of treating dyspnea associated with acute heart failure
    Patent number: 8372809
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: February 12, 2013
    Assignee: Corthera, Inc.
    Inventors: Elaine Unemori, Sam L Teichman, Gad Cotter, Dennis R Stewart, Martha J Whitehouse
  • METHOD OF TREATING DYSPNEA ASSOCIATED WITH ACUTE HEART FAILURE
    Publication number: 20120040902
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Application
    Filed: September 23, 2011
    Publication date: February 16, 2012
    Inventors: Elaine Unemori, Sam L. Teichman, Gad Cotter, Dennis R. Stewart, Martha Jo Whitehouse
  • METHOD FOR TREATING DYSPNEA ASSOCIATED WITH ACUTE HEART FAILURE
    Publication number: 20120040903
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Application
    Filed: May 15, 2009
    Publication date: February 16, 2012
    Inventors: Elaine Unemori, Sam L. Teichman, Gad Cotter, Dennis R. Stewart, Martha J. Whitehouse